Leap Therapeutics (LPTX) has significantly increased its investment in ZEC, acquiring an additional $18 million worth of the digital asset. This strategic move, announced via PRNewswire, sees the Nasdaq-listed company purchasing 29,869 ZEC at an average price of $602.63 per coin. This latest acquisition brings Leap Therapeutics' total ZEC holdings to an impressive 232,644 ZEC. The company has not released specific details regarding the reasoning behind this increased investment. However, this expansion suggests a bullish outlook on the future potential and use cases of ZEC within the rapidly evolving cryptocurrency landscape. The market will be watching closely to see how Leap Therapeutics leverages its substantial ZEC holdings. ```